Zomedica Corp ZOMDF

$0.09 +0.00 (1.09%)

Valuation

Market cap
90,645,000
Revenue TTM
$32,030,000
Net income TTM
$-81,860,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
-255.57%
Debt to equity
0.00

Trading

Volume
1,614,472
Avg volume
870,712
Day's range
$0.08 – $0.10
Shares out
979,950,000
Stochastic %K
70%
Beta
1.34
Analysts
—
Price target
$0.25

Price

Company profile

Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. It offers diagnostic products comprising TRUFORMA Bulk Acoustic Wave point of care diagnostic platform; TRUVIEW, a digital cystoscopy platform that offers automated slide preparation within the instrument; and VetGuardian, a zero-touch vital signs remote monitoring system. Th...

Show more

Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. It offers diagnostic products comprising TRUFORMA Bulk Acoustic Wave point of care diagnostic platform; TRUVIEW, a digital cystoscopy platform that offers automated slide preparation within the instrument; and VetGuardian, a zero-touch vital signs remote monitoring system. The company provides therapeutic products, including PulseVet electrohydraulic shockwave therapy platform; and Assisi Loop line of products, including the Assisi Loop, Assisi Loop Lounge, Assisi EquiLoop, and DentaLoop devices that treat pain and inflammation through delivery of targeted pulsed electromagnetic field focused energy. The company was formerly known as Zomedica Pharmaceuticals Corp. and changed its name to Zomedica Corp. in October 2020. Zomedica Corp. is headquartered in Ann Arbor, Michigan.

Industry
Medical Devices
Sector
Healthcare
Phone
734 369 2555
Website
https://www.zomedica.com
Address
1101 Technology Drive, Suite 100, Ann Arbor, United States

Latest news

No headlines yet.

Stocktwits

MyChicago Nov 5, 6:10 PM
$ZOMDF Go ZOMEDICA GO. You had a great earnings yesterday. Thank you To the CEO Larry Heaton and your team.
0 replies
Sindel2326 Nov 5, 5:46 PM 0 replies
Theunknowner Nov 5, 5:45 PM
$ZOMDF pos
0 replies
MyChicago Nov 5, 5:41 PM
$ZOMDF So close to Profibality, Earnings were GREAT. In a tough market, this is a good bet. BUY
0 replies
dale99 Nov 5, 5:36 PM
$ZOMDF Why is it that they can't get the SP to at least $1 dollar?
3 replies
MyChicago Nov 5, 5:29 PM
$ZOMDF Window will open soon for insider buying. Buy and Hold.
0 replies
Kevin89903 Nov 5, 5:21 PM
$ZOMDF BUY & HOLD !!! On the bright side our earnings were good and you can still buy before the insiders do.
0 replies
MyChicago Nov 5, 5:05 PM
$ZOMDF Earnings Yesterday. Good. Zomedica had revenue of $9.90M in the quarter ending September 30, 2026, with 22.29% growth. This brings the company's total for the last twelve months to $38.68M, up 31.33% year-over-year. In the year 2025, Zomedica had annual revenue of $32.03M with 17.39% growth.
0 replies